Key Dates

Related Announcements

RFA-CA-22-042 - Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

RFA-CA-22-043 - Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on November 8, 2022, from 1:00 PM to 2:00 PM Eastern Time, for the Funding Opportunity Announcements (FOAs), RFA-CA-22-042, “Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)” and RFA-CA-22-043, “Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required).”

NCI and NIDA staff will provide an overview of the FOAs, including goals and objectives, application instructions, and review criteria, and will be available to answer questions.

Potential applicants are encouraged to submit their questions in advance of the webinar to [email protected] by November 4, 2022.

Note: Questions about the scope of the FOAs will be addressed during the webinar; however, questions about investigators’ specific study aims will not be addressed in the webinar.

Webinar Information:

To join the Webinar, pre-registration is required through Webex at: https://cbiit.webex.com/cbiit/j.php?RGID=r1fdbf1b3ebae83c939434c8ca2662c85
After you register, you will receive instructions for joining the meeting.

Participation in this webinar, although encouraged for potential applicants, is optional, and is not required for the submission of an application in response to RFA-CA-22-042 and RFA-CA-22-043.

Inquiries

Please direct all inquiries to:

Rachel Grana Mayne, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-5899
Email: [email protected]